Inflammation in Diabetic Nephropathy
Diabetic nephropathy is the leading cause of end-stage kidney disease worldwide but current treatments remain suboptimal. This review examines the evidence for inflammation in the development and progression of diabetic nephropathy in both experimental and human diabetes, and provides an update on r...
Sábháilte in:
Príomhchruthaitheoirí: | Andy K.H. Lim, Greg H. Tesch |
---|---|
Formáid: | Revisão |
Teanga: | Béarla |
Foilsithe / Cruthaithe: |
2012
|
Rochtain ar líne: | https://doi.org/10.1155/2012/146154 https://downloads.hindawi.com/journals/mi/2012/146154.pdf |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
-
Inflammation in Diabetic Nephropathy
de réir: Lim, Andy K. H., et al.
Foilsithe / Cruthaithe: (2012) -
Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice
de réir: Andy K.H. Lim, et al.
Foilsithe / Cruthaithe: (2009) -
Diabetic nephropathy – complications and treatment
de réir: Andy K.H. Lim
Foilsithe / Cruthaithe: (2014) -
Diabetic nephropathy – complications and treatment
de réir: Lim, Andy KH
Foilsithe / Cruthaithe: (2014) -
Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis
de réir: F. Y. Chow, et al.
Foilsithe / Cruthaithe: (2004)